Study reveals how beneficial gut microbe breaks down mucus for health

A microbe found in the lower part of the gut that is associated with good health has been comprehensively analyzed and found to have a focused diet breaking down sugars locked away in mucus.

MS Pharma becomes Partner for the Commercialization of FYB202 / ustekinumab in the MENA Region – Biotech Investments

EQS-News: Formycon AG / Key word(s): Agreement MS Pharma becomes Partner for the Commercialization of FYB202 / ustekinumab in the MENA Region 09.12.2024 / 06:30

December 10, 2024

New approach to understanding chronic inflammation could lead to better cancer therapies

A recently published study led by Wayne State University on a new approach to understanding chronic inflammation could lead to new advancements in the treatment

December 5, 2024

Pandemic pounds: Study reveals COVID-19’s impact on pregnancy weight gain patterns

The study reveals that gestational weight gain (GWG) increased during the peak of the COVID-19 pandemic and plateaued in the later stages, affecting especially those

September 5, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.